S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Combining Dato‑DXD with immunotherapy
Heather McArthur presents BEGONIA data showing high response rates and durable responses when combining Dato‑DXD with PD‑L1 agents.
Play episode from 17:42
Transcript
